Coala-Life Group AB/News/Coala Life December monthly KPI’s USA

Coala Life December monthly KPI’s USA

12 January 2023 - 16:30

KPI’s December 2022:

Patients in RPM as of December 31, 2022: 3,500
Annual revenue rate as of December 31, 2022: 3.6 MUSD

Explanations of KPI’s
Patients in RPM as of December 31, 2022 – Number of patients that the company monitors in USA at the end of December.
Annual revenue rate as of December 31, 2022 – Estimated recurring revenue in USD based on December month’s revenue, measured at an annual rate.

Comments of KPI’s December 2022
The development is in line with the financial targets.

The figures in this press release are preliminary and unaudited.

About us

Coala-Life Group AB (“Coala Life” or the “Company”) founded in 2015, is a Cloud Based Software as a Service provider, and medical device developer and reseller, listed on Nasdaq First North Growth Market. The Company focuses on B2B solutions for managed Remote Patient Monitoring (“RPM”), offering medical care providers, primarily in the US, with a highly scalable, cost-efficient platform to remotely and virtually manage large volumes of patients suffering from chronic diseases. The company offers care providers a comprehensive solution and lifts the administrative work from the care providers regarding, amongst other things, follow-up, 24/7 monitoring, as well as the reimbursement process from state and private health insurance companies. Patients are monitored long-term in everyday life and typically have diabetes, obesity, and/or cardiovascular disease.
For more information see www.coalalife.com

Provided by: MFN

Coala-Life Group AB

Coala Life was founded in Sweden with a mission to develop patient-centric solutions powered by smart algorithms. The solutions aim to digitally transform the field of cardiac diagnostics, to help win the battle against the world’s leading cause of death - heart disease....

Learn more about company

Related news

23.03.2023

Monivent AB

Resultat från studie med Monivent Neo100 kommer presenteras på kongress i Washington

Dr Michael Wagner från det medicinska universitetssjukhuset i Wien kommer att presentera resultat från studien “Optimization of ventilation strategies in preterm and term infants in a single-center intervention study” vid Pediatric Academic Societies (PAS) årliga möte som hålls i Washigton 27...

23.03.2023

PolarCool AB

PolarCool AB (publ) meddelar nytt datum för årsstämman

Erik Andersson – VD PolarCool AB (publ) +46 - 738 60 57 00 &...

23.03.2023

Prostatype Genomics AB

Studie med gentestet Prostatype® publicerat i ledande internationell tidskrift

Studien som genomförts av ett forskningsteam på Akademiska sjukhuset i Uppsala under ledning av docent och överläkare Michael Häggman visar att gentestet Prostatype® korrekt bedömer prostatacancertumörens aggressivitet när man jämför genuttryck från vävnadsprover, så kallade biopsier, med ”fac...

23.03.2023

Cessatech A/S

Minutes from the Annual General Meeting in Cessatech A/S

ELECTION OF CHAIRMAN OF THE MEETING Mikkel Rostock-Jensen was elected chairman of the meeting. The chairman of the meeting ascertained that none of the shareholders objected to the legality of the annual general meeting and announced that the annual general meeting had been duly convened and...